Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract ...
"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which promises results in 30 minutes—for myself.
Discover MIDO 2025, showcasing advancements in eyewear and the role of 3D printing in enhancing business models.
2d
DPA International on MSNSiemens Energy starts year with profit despite wind power strugglesSiemens Energy got off to a solid start in the 2025 financial year, posting a profit of €252 million ($261 million) in the ...
1d
DPA International on MSNGerman conglomerate Siemens reports first quarter increase in profitSiemens, one of the largest manufacturing companies in Europe, reported a rise in profit for the first quarter, the company said on Thursday. The company's earnings totalled €3.705 billion ($3.8 ...
Bernstein analyst Lisa Bedell Clive maintained a Buy rating on Siemens Healthineers AG (SEMHF – Research Report) today and set a price target ...
J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) today and set ...
Siemens reports an increase in FQ1 net profit that beat market expectations, as the company continues to benefit from ...
Siemens Healthineers' CEO said on Thursday that the medical-technology company had a "very positive" view on considerations ...
German medical technology company Siemens Healthineers on Thursday reported first-quarter revenue slightly above consensus, rising 5.5% at market open, as its U.S. revenues increased by 16% while ...
Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The ...
Only Siemens makes the simultaneous acquisition of whole-body MR and PET possible. Molecular MR supports our joint vision for healthcare – to advance disease management and improve care for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results